Economy

After a 29% Slide YTD, Is UnitedHealth Stock Poised for a Rebound?

UnitedHealth Group (UNH), the largest private health insurer in the United States, has encountered a significant downturn in 2025. With a year-to-date (YTD) decline of 29%, the company has lost

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Economy

Jim Cramer on Centene (CNC): “Centene’s Doing Incredibly Well”

Centene Corporation (NYSE:CNC) has been making headlines recently, especially after the financial results of a major health insurer sent the

China says no ongoing trade talks with the U.S., calls for canceling ‘unilateral’ tariffs

China Denies Ongoing Discussions with U.S. on Tariffs The Ministry of Commerce in China made it clear on Thursday that

Russian missiles and drones target Kyiv in biggest attack in months

Unlock the White House Watch newsletter for free Are you looking for a comprehensive guide to understanding the implications of

Veteran Investor Bought More Caterpillar (CAT) Stock on Weakness

Kevin Simpson, the founder and CEO of Capital Wealth Planning, recently made a strategic move by purchasing more Caterpillar (CAT)

Chinese factories slow production and send workers home as tariffs bite

In response to the ongoing trade war initiated by US President Donald Trump, factories in China have started to feel

Taiwan Semiconductor (TSM) Target Trimmed to $215 as Analysts Say ‘Slowdown Makes Sense’

Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is a key player in the AI stocks market, competing fiercely with other tech

SK Hynix profits double on memory chip stockpiling ahead of US tariffs

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.

Is Gilead Sciences (GILD) a Cheap NASDAQ Stock to Buy According to Hedge Funds?

Gilead Sciences, Inc. (NASDAQ:GILD) is a biopharmaceutical company that has been in the spotlight recently as one of the cheap